➤ 15% of the developed world suffers IBS
➤ 800,000,000 people worldwide
➤ 26.9% of adults in the U.S.
➤ worldwide annual cost of $200,000,000
Current medical approaches show poor long term success and come with undesirable side effects.
Funding is needed to study dietary and environmental factors as well as psychologically related effects. Funding for research, unfortunately, is directed towards practices that are revenue generating. There are many promising lifestyle approaches but clinician success is poorly documented and viewed by the medical community as anecdotal.
Fortunately, patients are sharing their personal experiences which are valid, regardless what Big Pharma has to say.
Drossman, D., Camerilli, M., Mayer, A., whitehead, W., (2002). AGA technical review on irritable bowel syndrome. American Journal of Gastroenterology, 123;6:2108-2131
Camilleri, M., Sellin, J., Barrett, K., (2016). Pathophysiology, evaluation, and management of chronic watery diarrhea. Gastroenterology, doi: 10.1053/j.gastro.2016.10.014